Bici Biomedical Information is categorized under Services (Unclassified) in Walnut Creek, CA and active since 1996.
Bici Biomedical Information was established in 1996, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.
If you are seeking more information, feel free to contact Donald Ingenito at the company’s single location by writing to 1112 Rockledge Lane Apartment 9, Walnut Creek, California CA 94595 or by phoning (925) 280-8035. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Bici Biomedical Information |
Contact Person: | Donald Ingenito |
Address: | 1112 Rockledge Lane Apartment 9, Walnut Creek, California 94595 |
Phone Number: | (925) 280-8035 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1996 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Services (Unclassified) |
SIC Code: | 8999 |
NAICS Code: | 541990 |
Share This Business: |
Bici Biomedical Information was started in 1996 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Donald Ingenito for inquiries that concern Bici Biomedical Information by calling the company number (925) 280-8035, as your correspondence is most welcome. Additionally, the physical location of the single location of Bici Biomedical Information can be found at the coordinates as well as the street address 1112 Rockledge Lane Apartment 9 in Walnut Creek, California 94595.
For its online presence, you may visit Bici Biomedical Information’s website at and engage with its social media outlets through on Twitter and on Facebook.